Evidence map›Paper›PMID 42179638›Full record

ReviewACS omega2026

Benzazepines Derivatives: Synthetic Strategy, Structural-Activity Relationships, and Medical Potential as Dopamine and Serotonin Receptor Modulators.

Shweta Singh Verma, Amit Verma, Surendra Kumar Verma, Syed Misbahul Hasan, Lavkush Verma, Mohd Anas

Abstract readReview
In one paragraph

Review in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shweta Singh VermaDepartment of Pharmacy, Integral University, Lucknow, Uttar Pradesh 226026, India.ORCID https://orcid.org/0009-0007-8463-9782
Amit VermaSchool of Pharmacy, Chandigarh University, Lucknow-Kanpur Highway -27, Unnao 226001, Uttar Pradesh, India.
Surendra Kumar VermaSchool of Pharmacy, Chandigarh University, Lucknow-Kanpur Highway -27, Unnao 226001, Uttar Pradesh, India.
Syed Misbahul HasanDepartment of Pharmacy, Integral University, Lucknow, Uttar Pradesh 226026, India.
Lavkush VermaSchool of Pharmacy, Chandigarh University, Lucknow-Kanpur Highway -27, Unnao 226001, Uttar Pradesh, India.
Mohd AnasDepartment of Pharmacy, Integral University, Lucknow, Uttar Pradesh 226026, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Benzazepine derivatives make up a generalized group of nitrogen-bearing heterocycles, which have a wide range. pharmacological range, such as dopaminergic and serotonergic, analgesia, antihypertensive, and anticancer properties. Tetrahydro-3-benzazepine scaffolds are the most preferentially interacting ones among them, which have dopaminergic and serotonergic receptors, in particular, D2/D3- and 5-HT2A-, 5-HT2C-, and 5-HT2B-receptors. They are valuable templates to discover neuropsychiatric drugs, because they belong to the 5-HT6 class. This review systematically summarizes and contrasts the classical and contemporary synthetic methods, such as Pd-catalyzed intramolecular. Heck cyclization, Schmidt and Beckmann rearrangements, and ring-closing metathesis. Particular attention is given to organizing structure-activity relations (SAR), choosing receptors, and physicochemical determinants of ligand efficacy. Mechanistic and computational knowledge is also summarized to direct a rational scaffold. optimization. In general, this discussion demonstrates benzazepines as central nervous system privileged pharmacophores. system-active agents and suggests structure-directed approaches to defining the next-generation dopaminergic and/or strategies. serotonergic modulators.

Identifiers

PMID42179638
PMCPMC13191697

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.